Issue 333 of Al Rafid Magazine released
A major highlight of this issue is the honoring of His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, who received the
"Arab Cultural Merit Medal"
from ALECSO during a ceremony in Tunisia. The award recognizes His Highness's five decades of contributions to Arab and Islamic culture, including initiatives like the
"Historical Dictionary of the Arabic Language,"
the establishment of cultural centers in Europe and Africa, and his ongoing support for theatrical and artistic institutions.
Sharjah-Oman cultural ties
Under the theme
"A Window to Reflect on a Shared Historical Heritage,"
the issue also features the participation of His Highness Sheikh Sultan bin Ahmed Al Qasimi, Deputy Ruler of Sharjah, at the opening of the
"Masterpieces of Islamic Arts"
exhibition at the National Museum of Oman. This event reflects the deep historical relationship between the UAE and Oman.
Innovation and excellence in governance
The issue highlights His Highness Sheikh Sultan bin Ahmed's launch of the
"Institutional Excellence Award,"
which aims to foster innovation across both public and private sectors. It also covers his recognition of leading initiatives in governance and smart services.
Sheikha Bodour's role in cultural advancement
Special focus is given to the efforts of
Sheikha Bodour bint Sultan Al Qasimi
, Chairperson of the Sharjah Book Authority, in advancing the emirate's cultural influence. The issue features:
Her inauguration of the
fourth International Distributors Conference
, attended by 750 professionals from 94 countries
Her patronage of the
"Chapters of Islamic Art"
exhibition
Her launch of the
"Africa and the Arabian Peninsula"
symposium in partnership with global organisations
Scientific and academic achievements
The issue also showcases Sharjah's expanding contributions to science and education, including:
The launch of the
Al Qasimi Astronomical Observatory
, a new hub for space research
The
University of Sharjah's collaborations
with the Diplomatic Academy and Ministry of Climate Change
American University of Sharjah students
winning international architectural awards
The
Spring Life Skills Forum
, which supports youth creativity and innovation
Sharjah: A global cultural vision
Through its diverse content,
Al Rafid
Issue 333 reaffirms Sharjah's vision as a hub for creativity, committed to preserving cultural heritage while embracing modernity. It reflects the lasting influence of His Highness the Ruler of Sharjah in shaping the future of Arab culture and fostering global cultural dialogue.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
3 days ago
- Zawya
White hydrogen adds new dimension to Oman's energy transition
Oman has established itself as a regional leader in green hydrogen, driven by the Ministry of Energy and Minerals and Hydrom's successful launch of large-scale projects, competitive auctions, and the securing of international investments. Building on this momentum, the country is now turning its focus to white hydrogen, also known as natural hydrogen, geologic hydrogen, or gold hydrogen. A recent agreement between Sohar Port and Freezone and the Swiss company Hynat marks a key step in evaluating and developing the full value chain of this resource. This reflects Oman's ongoing commitment to diversifying its hydrogen portfolio in line with Oman Vision 2040 and the National Strategy for an Orderly Transition to Net Zero. White hydrogen forms naturally through geological processes and is stored in subsurface reservoirs. It does not require carbon-intensive production, offering a low-emission alternative suitable for industrial use, mobility systems, and export. If discovered in viable quantities with high purity, white hydrogen could strengthen Oman's energy sustainability, support export growth, and position the country as a frontrunner in a rapidly evolving global sector. Developing white hydrogen comes with several technical challenges. It is difficult to estimate how much hydrogen exists underground, where it is located, and how easily it can be recovered with the required purity. Even in high concentrations, hydrogen is often mixed with gases like nitrogen or methane, which must be removed using efficient and affordable methods. Hydrogen's small molecular size makes it prone to leakage through fractures in rocks or poorly sealed wells. To manage this, Oman needs better tools for subsurface imaging, reservoir modeling, and real-time monitoring. Long-term exposure to hydrogen can also weaken metals used in drilling and pipelines, requiring stronger materials and site-specific designs. Large-scale production will depend on safe and cost-effective systems for extraction, compression, storage, and handling. Innovations in drilling techniques, sealing materials, and surface infrastructure will be critical to achieving technical reliability and cost control. To unlock investment, detailed pre-feasibility and feasibility studies are essential to evaluate geological potential, infrastructure needs, project economics, and environmental impact. Artificial intelligence can support these efforts by predicting gas composition profiles, refining subsurface models, and designing more effective separation processes. Combined with techno-economic modeling, life cycle assessment, and geospatial analysis, these tools will enhance decision-making and reduce investment risks. Academic institutions such as Sultan Qaboos University can play a central role in advancing white hydrogen development through interdisciplinary research and curriculum innovation. Research platforms like the Oil and Gas Research Centre and the Sustainable Energy Research Centre can foster collaboration across petroleum engineering, chemical engineering, earth sciences, and environmental science. Priority research areas in white hydrogen include techno-economic feasibility studies, sustainability assessment, advanced gas separation techniques, subsurface hydrogen migration, AI-assisted gas composition prediction, and geospatial resource mapping. These efforts can help shape regulatory frameworks, guide pilot project design, and support evidence-based investment planning. At the same time, modernizing academic programs through specialized elective courses in white hydrogen systems, energy geoscience, and techno-economic analysis can help prepare a skilled workforce to meet the demands of this emerging sector. Oman is already leading the region's energy transition. White hydrogen adds a strategic new dimension, opening pathways for low-emission innovation and industrial growth. Through accelerated feasibility studies, advanced R&D, and strong partnerships, Oman can turn this emerging resource into a key pillar of energy security and economic resilience. 2025 © All right reserved for Oman Establishment for Press, Publication and Advertising (OEPPA) Provided by SyndiGate Media Inc. (
Zawya
3 days ago
- Zawya
Oman to produce medical diagnostic machines locally
A strategic Memorandum of Understanding (MoU) was signed by Dr Mohammad Mahmoodi, CEO of Carbon Technologies, and Dr Frank Vitzthum, Board Member and CTO of R-Biopharm, Germany, in the presence of Dr Rahma bint Ibrahim al Mahrouqiyah, Minister of Higher Education, Research and Innovation, on Tuesday. Under the MoU, advanced diagnostic manufacturing will be localised in Oman, supporting technology transfer and enhancing the country's health innovation ecosystem. The partnership will enable integration of state-of-the-art assay technologies into its local production lines, supporting both national and regional healthcare priorities. 'It is a milestone MoU in Oman's journey towards eliminating tuberculosis and other diseases from the country, and both communicable diseases and NCDs,' said Dr Rahma bint Ibrahim al Mahrouqiyah, Minister of Higher Education, Research and Innovation. 'I'm optimistic and this will pave the way for various scientific advancements in the country, especially when it is located near SQU and within the Innovation Park Muscat. We have begun, and we look forward to having an international consortium to eradicate both communicable and non-communicable diseases. We look forward to collaborating with regional, national and international partners so that we can cooperate with the leading players,' she added. Speaking to the Observer, Dr Mohammad Mahmoudi, Chief Executive Officer of Carbon Technologies, said that this collaboration is a testament to Oman's growing capacity in innovation-driven industries and its strategic openness to global partnerships. 'Together with R-Biopharm, we aim to elevate diagnostic standards, nurture Omani talent and contribute to national healthcare resilience,' Dr Mohammad added. Aligned with the objectives of Oman Vision 2040, the MoU supports national goals in biotechnology, scientific research and industrial innovation. Speaking on the sidelines of the signing ceremony, Eng Said bin Nasser al Salmi, Board Member of Carbon Technologies, said that the MoU would open up more opportunities to leverage Carbon Technologies as a leading Omani company and expand local R&D capabilities to serve both domestic and international markets in the healthcare industry and position Oman among the leading innovation hubs in such sectors. Dr Dirk Dressler, Head of Business Development at R-Biopharm AG, said, 'We are honoured to partner with Oman's Carbon Technologies. This collaboration reflects our confidence in Oman's capabilities and our shared commitment to delivering high-quality, accessible diagnostics across the region." 2025 © All right reserved for Oman Establishment for Press, Publication and Advertising (OEPPA) Provided by SyndiGate Media Inc. (
Zawya
5 days ago
- Zawya
The Royal Marsden Cancer Charity hails Sheikha Jawaher Al Qasimi's role in advancing precision medicine for cancer treatment
A humanitarian initiative by HH Sheikha Jawaher Al Qasimi, the lab was established with a £500,000 donation One of only two UK labs selected by NHS England to evaluate long-read whole genome sequencing for clinical application. Enhancing lung cancer genetic mutation analysis using 'Liquid Biopsy' technology Capacity has been doubled to deliver an additional ,000 genetic tests monthly Actively participating in clinical trials for DNA-based personalised therapies The Royal Marsden is a specialist cancer centre that brings together world class researchers and dedicated clinical teams providing expert compassionate care Sharjah: The Royal Marsden Cancer Charity; which supports the work of The Royal Marsden; has commended the significant support of Her Highness Sheikha Jawaher bint Mohammed Al Qasimi, Wife of the Ruler of Sharjah and Founder/Royal Patron of the Friends of Cancer Patients (FoCP). Its annual report highlighted her contributions to advancing cancer research, particularly through initiatives over the past five years that have accelerated progress at the Sharjah Clinical Genomics Laboratory within the National Institute for Health and Care Research (NIHR) Centre for Molecular Pathology (CMP); housed within The Royal Marsden in the UK. These efforts have greatly enhanced faster delivery of precise diagnoses and cutting-edge personalised treatments for patients. The report underscored that Her Highness's support has empowered the lab's scientific team to fast-track diagnostics and treatments, bringing hope to thousands of patients. This was achieved through the introduction of state-of-the art facilities to the Sharjah Clinical Genomics Laboratory; including the UK's first robotic genome testing facility; and bringing together world experts in molecular pathology, bioinformatics, translational research. A humanitarian grant has been driving rapid progress The Sharjah Laboratory was launched in 2018 as a humanitarian initiative by Her Highness Sheikha Jawaher Al Qasimi, who donated £500,000 to support its establishment within the CMP at The Royal Marsden in the UK. This donation reflects Her Highness's strong belief that investing in scientific research is foundational in the fight against cancer and that such research can make a genuine global impact, benefiting patients far beyond the institution itself. Founded in 1851, The Royal Marsden in London is the world's first and most renowned cancer centers. It specialises in the diagnosis, treatment, and research of all types of cancer, with a highly experienced medical team and a dedicated department for paediatric and adolescent care. The hospital serves more than 50,000 patients annually and works in close collaboration with its academic partner, The Institute of Cancer Research, London, cementing its position as a global leader in cancer treatment innovation. Recent advancements enhancing cancer care Recent advancements at the CMP are enhancing cancer care and were reflected in a comprehensive report. The 'Marsden360' service, developed in partnership with Guardant Health, uses liquid biopsy (a blood test for cancer) to identify the genetic changes in DNA, allowing patients to be matched to targeted treatments. The testing was offered as part of an NHS England national study for patients with suspected late-stage lung cancer, as well as providing a commissioned NHS ctDNA service to guide treatment decisions for eligible patients with suspected late-stage breast cancer. The report also noted the Sharjah Clinical Genomics Laboratory is on track to become the first facility in the UK to offer fully automated genomic testing, with the capacity to conduct 5000 tests monthly. This is being achieved through collaboration with Automata, a global biotech company providing robotic automation solutions to the life sciences industry. The advancement has improved early detection of genetic mutations and enabled proactive care for high-risk cancer patients. Cutting-edge technology includes the Nanopore PromethION device for precise long-read DNA sequencing, already analyzing 110 whole genomes to yield new insights for treatment development. The CMP also plays a vital role in key clinical trials like 'ENABLE-NGS', 'PREVAIL', and 'ICED' (targeting leukemia, lung, and rare cancers), 'SIGNIFIED' (offering annual scans for Li-Fraumeni Syndrome), 'INOVATE' (blood-based monitoring for head/neck cancers), and 'RECUT Plus' (studying radiotherapy resistance). Further amplifying its impact, the lab contributed to over 24 peer-reviewed studies in 2024, presented at major conferences like ESMO and ASCO, exploring molecular profiling to redefine cancer risk and reshape treatment strategies. A UAE humanitarian vision for the world The Sharjah Clinical Genomics Laboratory reflects the UAE's vision of investing in human potential and scientific research, transforming humanitarian efforts into tangible impact in patients' lives. It serves as a prime example of successful collaboration between philanthropy and science, through which Sharjah has become an active partner and contributor to the future of genomic medicine worldwide. The laboratory's success in the UK exemplified the vision and commitment of Her Highness Sheikha Jawaher Al Qasimi commitment to supporting cancer patients. Her Highness's efforts have directly supported several specialised institutions such as Children's Cancer Hospital Egypt 57357, the Children's Cancer Center of Lebanon (CCCL), the National Cancer Institute in Egypt (Sheikha Jawaher Al Qasimi Building), and the Union for International Cancer Control's (UICC) Fund for Childhood Cancer Patients. Through these efforts, Her Highness Sheikha Jawaher Al Qasimi champions a UAE global humanitarian mission that transcends borders.
